Clinical observation on salmeterol xinafoate and fluticasone propionate in treating cough variant asthma in children / 中国基层医药

ABSTRACT

Objective To investigate the effect of salmeterol xinafoate and fluticasone propionate in treat-ment of children's cough variant asthma(CVA) and its safety. Methods Sixty-five children with CVA were ran-domly divided into treatment group (n = 32) and control group (n = 33). The control group was given orally amin-ophylline, and the treatment group was treated with salmeterol xinafoate and fluticasone propionate powder for inhala-tion. Results The improving rate of treatment group was significantly higher than that of control group (56% vs 27%, P < 0.05). The total effective rate of treatment group was significantly higher than that of control group (97% vs 77%, P < 0.05), and few side effects occurred. Conclusion It is effective and convenient that salmeterol xin-afoate and fluticasone propionate powder for inhalation in treatment of children' s CVA.